1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. Global prefilled syringes MARKET BY type
5.1. Introduction
5.2. Conventional Prefilled Syringes
5.3. Safety Prefilled Syringes
6. Global prefilled syringes MARKET BY material
6.1. Introduction
6.2. Glass
6.3. Plastic/Polymer
7. Global prefilled syringes MARKET BY design
7.1. Introduction
7.2. Single-Chamber
7.3. Dual-Chamber
7.4. Customized/Multiple-Chamber
8. Global prefilled syringes MARKET BY closing system
8.1. Introduction
8.2. Staked Needle System
8.3. Luer Cone System
8.4. Luer Lock System
9. Global prefilled syringes MARKET BY application
9.1. Introduction
9.2. Vaccines and Immunizations
9.3. Diabetes
9.4. Rheumatoid Arthritis
9.5. Oncology/Cancer
9.6. Anaphylaxis
9.7. Thrombosis
9.8. Ophthalmology
9.9. Autoimmune Diseases
9.10. Others
10. Global prefilled syringes MARKET BY END-USERs
10.1. Introduction
10.2. Hospitals and Clinics
10.3. Ambulatory Surgery Centers
10.4. Pharmaceutical & Biotechnology Companies
10.5. Mail Order Pharmacies
10.6. Home Care Settings Others
11. Global prefilled MARKET BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. United States
11.2.2. Canada
11.2.3. Mexico
11.3. South America
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Others
11.4. Europe
11.4.1. Germany
11.4.2. France
11.4.3. United Kingdom
11.4.4. Spain
11.4.5. Others
11.5. Middle East and Africa
11.5.1. Saudi Arabia
11.5.2. UAE
11.5.3. Others
11.6. Asia Pacific
11.6.1. China
11.6.2. India
11.6.3. Japan
11.6.4. South Korea
11.6.5. Indonesia
11.6.6. Thailand
11.6.7. Others
12. COMPETITIVE ENVIRONMENT AND ANALYSIS
12.1. Major Players and Strategy Analysis
12.2. Market Share Analysis
12.3. Mergers, Acquisitions, Agreements, and Collaborations
12.4. Competitive Dashboard
13. COMPANY PROFILES
13.1. Chemi S.p.A.
13.2. Catalent, Inc.
13.3. Becton, Dickinson and Company
13.4. Nipro Corporation
13.5. Taisei Kako Co. Ltd.
13.6. MEDEFIL, INC.
13.7. Alfasigma S.p.A
13.8. Aquabiliti
13.9. Schott Pharma (formerly SCHOTT AG)
13.10. Vetter Pharma International GmbH
13.11. Gerresheimer AG
13.12. West Pharmaceutical, Inc.
14. APPENDIX
14.1. Currency
14.2. Assumptions
14.3. Base and Forecast Years Timeline
14.4. Key benefits for the stakeholders
14.5. Research Methodology
14.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES